Neutralizing activity to SARS‐CoV‐2 of convalescent and control plasma used in a randomized controlled trial

BACKGROUND: There are limited data on the neutralizing activity of convalescent plasma (CP) administered in randomized controlled trials (RCT) of COVID‐19 infection. STUDY DESIGN AND METHODS: As part of an RCT, CP was collected per FDA guidelines from individuals recovered from COVID‐19 infection. C...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Transfusion
Auteurs principaux: Freedenberg, Alex T., Pan, Chun‐Hao, Diehl, William E., Romeiser, Jamie L., Hwang, Ga‐Ram, Leiton, Cindy V., Muecksch, Frauke, Shroyer, Kenneth R., Bennett‐Guerrero, Elliott
Format: Artigo
Langue:Inglês
Publié: John Wiley & Sons, Inc. 2021
Sujets:
Brief Reports
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8014203/
https://ncbi.nlm.nih.gov/pubmed/33448402
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/trf.16283
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires